DE60022174D1 - Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir - Google Patents
Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoirInfo
- Publication number
- DE60022174D1 DE60022174D1 DE60022174T DE60022174T DE60022174D1 DE 60022174 D1 DE60022174 D1 DE 60022174D1 DE 60022174 T DE60022174 T DE 60022174T DE 60022174 T DE60022174 T DE 60022174T DE 60022174 D1 DE60022174 D1 DE 60022174D1
- Authority
- DE
- Germany
- Prior art keywords
- present
- polyurethane
- transdermale
- drug administration
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12741299P | 1999-04-01 | 1999-04-01 | |
US127412P | 1999-04-01 | ||
PCT/US2000/008670 WO2000059483A2 (en) | 1999-04-01 | 2000-03-31 | Transdermal drug delivery devices comprising a polyurethane drug reservoir |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60022174D1 true DE60022174D1 (de) | 2005-09-29 |
DE60022174T2 DE60022174T2 (de) | 2006-02-16 |
Family
ID=22429983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60022174T Expired - Fee Related DE60022174T2 (de) | 1999-04-01 | 2000-03-31 | Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050048104A1 (de) |
EP (1) | EP1169025B1 (de) |
JP (1) | JP2002541094A (de) |
KR (1) | KR100622332B1 (de) |
AT (1) | ATE302598T1 (de) |
AU (1) | AU3932600A (de) |
CA (1) | CA2367100A1 (de) |
DE (1) | DE60022174T2 (de) |
ES (1) | ES2244422T3 (de) |
HK (1) | HK1043317B (de) |
WO (1) | WO2000059483A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020004065A1 (en) | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US20050100588A1 (en) * | 2001-06-13 | 2005-05-12 | Beiersdorf Ag | Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
JP4295467B2 (ja) | 2002-04-12 | 2009-07-15 | 日東電工株式会社 | 貼付剤およびその製造方法 |
US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
IL166687A0 (en) | 2002-08-30 | 2006-01-15 | Alza Corp | Embossable and writable multilaminate backing construction |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
US20040258742A1 (en) * | 2003-04-11 | 2004-12-23 | Van Osdol William Woodson | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines |
JP2007532645A (ja) * | 2004-04-13 | 2007-11-15 | アルザ コーポレイション | フェンタニルに基づく薬剤の経皮送達システム用の器具および方法 |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
JP4943676B2 (ja) * | 2005-07-25 | 2012-05-30 | タキロン株式会社 | 経皮薬貼付用基材 |
US9056061B2 (en) * | 2005-09-23 | 2015-06-16 | Alza Corporation | Transdermal nicotine salt delivery system |
US8383149B2 (en) | 2005-09-23 | 2013-02-26 | Alza Corporation | High enhancer-loading polyacrylate formulation for transdermal applications |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
JP5241714B2 (ja) | 2006-07-07 | 2013-07-17 | プロテウス デジタル ヘルス, インコーポレイテッド | スマートな非経口送達システム |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
GB0620685D0 (en) * | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
ES2385231T3 (es) | 2007-07-04 | 2012-07-19 | Acino Ag | Sistema de depósito con una membrana cerrada |
WO2009055733A1 (en) | 2007-10-25 | 2009-04-30 | Proteus Biomedical, Inc. | Fluid transfer port information system |
RU2549473C2 (ru) * | 2008-09-30 | 2015-04-27 | Эндо Фармасьютикалз Солюшнз Инк. | Имплантируемое устройство для доставки октреотида и способы его применения |
WO2010090346A1 (ja) * | 2009-02-06 | 2010-08-12 | セーレン株式会社 | 貼付材用フィルム基材および貼付材 |
EP2531096A4 (de) | 2010-02-01 | 2013-09-11 | Proteus Digital Health Inc | Datensammelsystem für zwei handgelenke |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
FR2992325B1 (fr) | 2012-06-26 | 2015-05-22 | Ab7 Innovation | Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication |
US20150104495A1 (en) * | 2012-10-25 | 2015-04-16 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine |
TWI632923B (zh) | 2012-10-25 | 2018-08-21 | 諾芬藥品公司 | 用於經皮傳遞安非他命(amphetamine)之組合物及方法 |
CN109715692B (zh) | 2016-09-19 | 2021-09-07 | 美国陶氏有机硅公司 | 皮肤接触粘合剂及其制备和使用方法 |
JP6816264B2 (ja) | 2016-09-19 | 2021-01-20 | ダウ シリコーンズ コーポレーション | ポリウレタン−ポリオルガノシロキサンコポリマー及びその調製方法 |
WO2018052645A1 (en) | 2016-09-19 | 2018-03-22 | Dow Corning Corporation | Skin contact adhesive and methods for its preparation and use |
US20210284840A1 (en) | 2016-09-19 | 2021-09-16 | Dow Silicones Corporation | Copolymer composition for coating and adhesive applications |
US20200297654A1 (en) | 2017-10-17 | 2020-09-24 | Lubrizol Advanced Materials, Inc. | Composition and device for delivery of active agents to skin surfaces |
KR200489477Y1 (ko) * | 2018-04-18 | 2019-06-24 | 김송호 | 반려동물의 발바닥 패치 |
JP7066508B2 (ja) * | 2018-05-02 | 2022-05-13 | 株式会社ニトムズ | ポリウレタン積層シートおよび粘着シート |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598122A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3731683A (en) * | 1971-06-04 | 1973-05-08 | Alza Corp | Bandage for the controlled metering of topical drugs to the skin |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
DE2541339A1 (de) * | 1975-09-17 | 1977-03-24 | Basf Ag | Verfahren zur herstellung von polyurethanklebstoffen |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4129566A (en) * | 1978-02-15 | 1978-12-12 | E. R. Squibb & Sons, Inc. | Derivatives of dehydrocyclicimino acids |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
US4314557A (en) * | 1980-05-19 | 1982-02-09 | Alza Corporation | Dissolution controlled active agent dispenser |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4849226A (en) * | 1981-06-29 | 1989-07-18 | Alza Corporation | Method for increasing oxygen supply by administering vasodilator |
US4725272A (en) * | 1981-06-29 | 1988-02-16 | Alza Corporation | Novel bandage for administering beneficial drug |
US4523005A (en) * | 1981-10-30 | 1985-06-11 | Thermedics, Inc. | Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1,4-butane diol |
US4435180A (en) * | 1982-05-25 | 1984-03-06 | Alza Corporation | Elastomeric active agent delivery system and method of use |
US4483759A (en) * | 1982-07-02 | 1984-11-20 | Thermedics, Inc. | Actinic radiation cured polyurethane acrylic copolymer |
US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
FR2542998B1 (fr) * | 1983-03-24 | 1986-01-31 | Rhone Poulenc Sante | Nouvelle forme transdermale du dinitrate d'isosorbide |
US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4704282A (en) * | 1984-06-29 | 1987-11-03 | Alza Corporation | Transdermal therapeutic system having improved delivery characteristics |
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
US4638043A (en) * | 1984-11-13 | 1987-01-20 | Thermedics, Inc. | Drug release system |
US4614787A (en) * | 1984-11-13 | 1986-09-30 | Thermedics, Inc. | Drug dispensing wound dressing |
US4645502A (en) * | 1985-05-03 | 1987-02-24 | Alza Corporation | Transdermal delivery of highly ionized fat insoluble drugs |
US4904475A (en) * | 1985-05-03 | 1990-02-27 | Alza Corporation | Transdermal delivery of drugs from an aqueous reservoir |
US4698062A (en) * | 1985-10-30 | 1987-10-06 | Alza Corporation | Medical device for pulsatile transdermal delivery of biologically active agents |
US5066648A (en) * | 1985-11-29 | 1991-11-19 | Merck & Co., Inc. | Pyroglutamic acid esters used as dermal penetration enhancers for drugs |
DE3780700T2 (de) * | 1986-05-14 | 1993-02-04 | Takiron Co | Klebstoff fuer perkutane verabreichung. |
ATE71287T1 (de) * | 1986-06-13 | 1992-01-15 | Alza Corp | Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit. |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US5344656A (en) * | 1986-09-12 | 1994-09-06 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
US4908027A (en) * | 1986-09-12 | 1990-03-13 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
AU607172B2 (en) * | 1986-12-22 | 1991-02-28 | Cygnus, Inc. | Diffusion matrix for transdermal drug administration |
AU601528B2 (en) * | 1986-12-22 | 1990-09-13 | Ortho-Mcneil Pharmaceutical, Inc. | Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers |
US5006342A (en) * | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
US4788062A (en) * | 1987-02-26 | 1988-11-29 | Alza Corporation | Transdermal administration of progesterone, estradiol esters, and mixtures thereof |
US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
US5071656A (en) * | 1987-03-05 | 1991-12-10 | Alza Corporation | Delayed onset transdermal delivery device |
US5186939A (en) * | 1987-04-23 | 1993-02-16 | Cygnus Therapeutic Systems | Laminated composite for transdermal administration of fentanyl |
US5273757A (en) * | 1987-09-01 | 1993-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Apparatus for the delivery of substances, processes for the production thereof and use thereof |
US4943435A (en) * | 1987-10-05 | 1990-07-24 | Pharmetrix Corporation | Prolonged activity nicotine patch |
US4917895A (en) * | 1987-11-02 | 1990-04-17 | Alza Corporation | Transdermal drug delivery device |
US4781924A (en) * | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US4840796A (en) * | 1988-04-22 | 1989-06-20 | Dow Corning Corporation | Block copolymer matrix for transdermal drug release |
US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
US5156911A (en) * | 1989-05-11 | 1992-10-20 | Landec Labs Inc. | Skin-activated temperature-sensitive adhesive assemblies |
US5118779A (en) * | 1989-10-10 | 1992-06-02 | Polymedica Industries, Inc. | Hydrophilic polyurethane elastomers |
NZ237241A (en) * | 1990-03-02 | 1993-11-25 | Pharmetrix Corp | Method for increasing the storage stability of physostigmine |
KR950005865B1 (ko) * | 1990-04-23 | 1995-06-02 | 데이진 가부시끼가이샤 | 첩부제 |
US6294346B1 (en) * | 1991-07-08 | 2001-09-25 | Neurospheres Holdings, Ltd. | Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents |
CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
US6010715A (en) * | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
ZA933349B (en) * | 1992-05-13 | 1994-06-15 | Alza Corp | Transdermal administration of oxybutynin |
DE4230588C1 (de) * | 1992-09-12 | 1993-10-07 | Lohmann Therapie Syst Lts | Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung |
US5294342A (en) * | 1992-10-01 | 1994-03-15 | Hoechst Celanese Corporation | Composite porous membranes |
DE4301781C2 (de) * | 1993-01-23 | 1995-07-20 | Lohmann Therapie Syst Lts | Nitroglycerinhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung |
DE4308649C2 (de) * | 1993-03-18 | 1995-11-16 | Lohmann Gmbh & Co Kg | Medizinisches Pflastermaterial sowie Verfahren zu seiner Herstellung und dessen Verwendung |
US5762952A (en) * | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
CA2127173A1 (en) * | 1993-07-20 | 1995-01-21 | Frank S. Castellana | Medical dressing with semi-peripheral delivery system and methods therefor |
JP2579426B2 (ja) * | 1993-09-29 | 1997-02-05 | インターナショナル・ビジネス・マシーンズ・コーポレイション | 液晶電気光学素子 |
JP3240496B2 (ja) * | 1993-09-30 | 2001-12-17 | タキロン株式会社 | 経皮吸収製剤 |
WO1995022970A1 (fr) * | 1994-02-28 | 1995-08-31 | Teijin Limited | Timbre renfermant du dinitrate d'isosorbide et etant prepare a l'aide d'un melange adhesif |
US5391406A (en) * | 1994-03-25 | 1995-02-21 | National Starch And Chemical Investment Holding Corporation | Process of preparing hot melt pressure sensitive adhesives on a substrate |
US5505958A (en) * | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
US5688523A (en) * | 1995-03-31 | 1997-11-18 | Minnesota Mining And Manufacturing Company | Method of making a pressure sensitive skin adhesive sheet material |
US5569683A (en) * | 1995-05-22 | 1996-10-29 | Thermedics, Inc. | Gel compositions |
EP0907359B1 (de) * | 1995-09-14 | 2001-12-12 | Ortho-McNeil Pharmaceutical, Inc. | Polyurethan-hydrogel arzneistoffreservoirs zur verwendung in transdermalen arzneistoffverabreichungssystemen |
TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
GB9614098D0 (en) * | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
-
2000
- 2000-03-31 CA CA002367100A patent/CA2367100A1/en not_active Abandoned
- 2000-03-31 DE DE60022174T patent/DE60022174T2/de not_active Expired - Fee Related
- 2000-03-31 EP EP00918530A patent/EP1169025B1/de not_active Expired - Lifetime
- 2000-03-31 AU AU39326/00A patent/AU3932600A/en not_active Abandoned
- 2000-03-31 ES ES00918530T patent/ES2244422T3/es not_active Expired - Lifetime
- 2000-03-31 JP JP2000609047A patent/JP2002541094A/ja active Pending
- 2000-03-31 KR KR1020017012581A patent/KR100622332B1/ko not_active IP Right Cessation
- 2000-03-31 WO PCT/US2000/008670 patent/WO2000059483A2/en active IP Right Grant
- 2000-03-31 AT AT00918530T patent/ATE302598T1/de not_active IP Right Cessation
-
2002
- 2002-07-08 HK HK02105063.9A patent/HK1043317B/zh not_active IP Right Cessation
-
2003
- 2003-06-30 US US10/611,531 patent/US20050048104A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1169025B1 (de) | 2005-08-24 |
WO2000059483A2 (en) | 2000-10-12 |
DE60022174T2 (de) | 2006-02-16 |
ATE302598T1 (de) | 2005-09-15 |
KR100622332B1 (ko) | 2006-09-13 |
HK1043317A1 (en) | 2002-09-13 |
HK1043317B (zh) | 2006-02-10 |
AU3932600A (en) | 2000-10-23 |
CA2367100A1 (en) | 2000-10-12 |
ES2244422T3 (es) | 2005-12-16 |
KR20010112391A (ko) | 2001-12-20 |
JP2002541094A (ja) | 2002-12-03 |
US20050048104A1 (en) | 2005-03-03 |
EP1169025A2 (de) | 2002-01-09 |
WO2000059483A3 (en) | 2001-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60022174D1 (de) | Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir | |
DE60023520D1 (de) | Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung | |
BR9506470A (pt) | Composição adesiva sensível a pressão para sistema de distribuição transdêrmica processo de distribuir drogas de modo transdérmico e processo de prepapar composição adesiva sensível à pressão para distribuir transdérmica de droga | |
DE69314650T2 (de) | Verpackungsmaterial und vorrichtung zur transdermalen arzneimittelabgabe | |
DK1133269T3 (da) | Kontrolleret afgivelsesindretning til indgift af terapeutika i det indre öre | |
DK1284656T3 (da) | Opretningsindretning til fremföring af en usymmetrisk indretning med en forudbestemt orientering | |
EP1025843A3 (de) | Druckempfindliche Klebemittel für Vorrichtungen zur transdermalen Wirkstoffverabreichung | |
WO2009003125A8 (en) | Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs | |
ATE535212T1 (de) | Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit | |
TW200600126A (en) | Method and device for targeted delivery of medicinal, cosmetic, and related agents | |
DE69204236T2 (de) | Polysiloxandruckempfindliche Klebemittel für Vorrichtungen zur transdermalen Wirkstoffabgabe und solche Vorrichtungen. | |
DE69121881D1 (de) | Hautelektrodenaufbau und dazugehöriges gerät zur transdermalen verabreichung von heilmitteln | |
EP0887075A3 (de) | Klebstoffmasse zur transdermalen Verabreichung von stark weichmachenden Wirkstoffen | |
ATE267004T1 (de) | Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen | |
WO2001015671A3 (en) | Flushable disposable polymeric products | |
ATE233545T1 (de) | Vorrichtung für ionophoretischen verabreichung mit polymerschaumbehältern | |
FI951169A0 (fi) | Dexpantenolia sisältävä laastari seterodihormonien transdermaaliseen käyttöön | |
DK0474647T3 (da) | Fremgangsmåde og indretning til frigivelse af lægemidler til huden | |
BR0209158A (pt) | Sistema de embalagem para sistemas de liberação de droga transdérmicos | |
DE60101206D1 (de) | Transdermale verabreichung von lasofoxifen | |
MY129063A (en) | Transdermal delivery of lasofoxifene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |